Keywords: |
clinical trial; review; multimodality cancer therapy; radiation dose; chemotherapy, adjuvant; combined modality therapy; lymph node excision; lymphadenectomy; controlled clinical trial; neoplasm recurrence, local; randomized controlled trial; radiotherapy dosage; risk factors; pathology; breast neoplasms; risk factor; cancer invasion; randomized controlled trials; tumor recurrence; adjuvant chemotherapy; breast tumor; carcinoma; neoplasm invasiveness; segmental mastectomy; mastectomy, segmental; humans; human; female
|